Abstract B077: Signatures of T-cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang(King Center), Xiaole Shirley Liu(Dana-Farber Cancer Institute), Myles Brown(Harvard University), Nicole Traugh(Tongji University), Jingxin Fu(Tongji University), Xihao Hu(Dana-Farber Cancer Institute), Gordon J. Freeman(Dana-Farber Cancer Institute), Deng Pan(University of Kentucky), Xia Bu(Tongji University), Avinash Sahu(New Mexico Department of Health), Jun Liu(Chongqing Population and Family Planning Science and Technology Research Institute), Bo Li(Children's Hospital of Philadelphia), Shengqing Gu(Dana-Farber Cancer Institute), Ziyi Li(Tongji University), Kai W. Wucherpfennig(Dana-Farber Cancer Institute)
Cited by 10
Related Papers
Model-based Analysis of ChIP-Seq (MACS)
|Genome biology|2008|20k
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
|Trends in Microbiology|2016|3.1k
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
|Genome biology|2016|2.8k
Identifying ChIP-seq enrichment using MACS
|Nature Protocols|2012|2.1k